A citation-based method for searching scientific literature

Takahiro Eitsuka, Kiyotaka Nakagawa, Shunji Kato, Junya Ito, Yurika Otoki, Soo Takasu, Naoki Shimizu, Takumi Takahashi, Teruo Miyazawa. Int J Mol Sci 2018
Times Cited: 14







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
74
28

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
21

Treating Cancer by Targeting Telomeres and Telomerase.
Marko Ivancich, Zachary Schrank, Luke Wojdyla, Brandon Leviskas, Adijan Kuckovic, Ankita Sanjali, Neelu Puri. Antioxidants (Basel) 2017
48
21

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
21

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
212
21

Telomerase Regulation from Beginning to the End.
Deanna Elise MacNeil, Hélène Jeanne Bensoussan, Chantal Autexier. Genes (Basel) 2016
46
14



Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
562
14


Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
Ohki Higuchi, Kiyotaka Nakagawa, Tsuyoshi Tsuzuki, Toshihide Suzuki, Shinichi Oikawa, Teruo Miyazawa. J Lipid Res 2006
27
14

Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
Kiyotaka Nakagawa, Jeong-Ho Oak, Ohki Higuchi, Tsuyoshi Tsuzuki, Shinichi Oikawa, Haruhisa Otani, Masatoshi Mune, Hua Cai, Teruo Miyazawa. J Lipid Res 2005
52
14


Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo.
J R Requena, M U Ahmed, C W Fountain, T P Degenhardt, S Reddy, C Perez, T J Lyons, A J Jenkins, J W Baynes, S R Thorpe. J Biol Chem 1997
71
14

Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood.
A Ravandi, A Kuksis, L Marai, J J Myher, G Steiner, G Lewisa, H Kamido. FEBS Lett 1996
65
14

Development of quantitation method for glycated aminophospholipids at the molecular species level in powdered milk and powdered buttermilk.
Ai Kodate, Yurika Otoki, Naoki Shimizu, Junya Ito, Shunji Kato, Naoki Umetsu, Teruo Miyazawa, Kiyotaka Nakagawa. Sci Rep 2018
8
25



Vaccination of patients with cutaneous melanoma with telomerase-specific peptides.
Robert E Hunger, Kristin Kernland Lang, Carrie J Markowski, Sissel Trachsel, Mona Møller, Jon A Eriksen, Anne-Marie Rasmussen, Lasse R Braathen, Gustav Gaudernack. Cancer Immunol Immunother 2011
31
14


Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.
Robert H Vonderheide, Susan M Domchek, Joachim L Schultze, Daniel J George, Kara M Hoar, Dih-Yih Chen, Katherine F Stephans, Kenkichi Masutomi, Massimo Loda, Zhinan Xia,[...]. Clin Cancer Res 2004
191
14

A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
Athanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, Despoina Aggouraki, Eleftheria Kleio Dermitzaki, Dora Hatzidaki, Nikolaos Kentepozidis, Dimitris Mavroudis, Vassilis Georgoulias. Lung Cancer 2014
35
14

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Zhen Su, Jens Dannull, Benjamin K Yang, Philipp Dahm, Doris Coleman, Donna Yancey, Sylvia Sichi, Donna Niedzwiecki, David Boczkowski, Eli Gilboa,[...]. J Immunol 2005
250
14

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Jeanne Menez-Jamet, Catherine Gallou, Aude Rougeot, Kostas Kosmatopoulos. Ann Transl Med 2016
17
14

Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.
Mark M Aloysius, Alastair J Mc Kechnie, Richard A Robins, Chandan Verma, Jennifer M Eremin, Farzin Farzaneh, Nagy A Habib, Joti Bhalla, Nicola R Hardwick, Sukchai Satthaporn,[...]. J Transl Med 2009
24
14

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.
Tim F Greten, Alejandro Forner, Firouzeh Korangy, Gisele N'Kontchou, Nathalie Barget, Carmen Ayuso, Lars A Ormandy, Michael P Manns, Michel Beaugrand, Jordi Bruix. BMC Cancer 2010
128
14

Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Philip W Kantoff, Celestia S Higano, Neal D Shore, E Roy Berger, Eric J Small, David F Penson, Charles H Redfern, Anna C Ferrari, Robert Dreicer, Robert B Sims,[...]. N Engl J Med 2010
14

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Paal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, Gunnar Kvalheim, Carrie J Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A Eriksen,[...]. Cancer Immunol Immunother 2006
161
14

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
Wolfgang Lilleby, Gustav Gaudernack, Paal F Brunsvig, Ljiljana Vlatkovic, Melanie Schulz, Kate Mills, Knut Håkon Hole, Else Marit Inderberg. Cancer Immunol Immunother 2017
38
14

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
14

Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients.
Caroline Staff, Fariba Mozaffari, Jan-Erik Frödin, Håkan Mellstedt, Maria Liljefors. Int J Oncol 2014
35
14

Telomerase-based therapies emerging slowly.
Vicki Brower. J Natl Cancer Inst 2010
22
14

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca,[...]. Cancer Immunol Immunother 2013
38
14

Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.
Daniela Fenoglio, Alessia Parodi, Rosa Lavieri, Francesca Kalli, Francesca Ferrera, Augusto Tagliamacco, Andrea Guastalla, Maria Giuseppina Lamperti, Mauro Giacomini, Gilberto Filaci. Hum Vaccin Immunother 2015
22
14


Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
188
14

Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
Hanna J Khoury, Robert H Collins, William Blum, Patrick S Stiff, Laurence Elias, Jane S Lebkowski, Anita Reddy, Kevin P Nishimoto, Debasish Sen, Edward D Wirth,[...]. Cancer 2017
43
14

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001.
Else-Marit Inderberg-Suso, Sissel Trachsel, Kari Lislerud, Anne-Marie Rasmussen, Gustav Gaudernack. Oncoimmunology 2012
64
14

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14



TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer.
Flavio Salazar-Onfray, Cristián Pereda, Diego Reyes, Mercedes N López. Biol Res 2013
11
18

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients.
Jon Amund Kyte, Gustav Gaudernack, Svein Dueland, Sissel Trachsel, Lars Julsrud, Steinar Aamdal. Clin Cancer Res 2011
73
14

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.
Shikhar Mehrotra, Carolyn D Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A Cloud, Mingli Li, Gina Scurti, Mohamed L Salem, Michelle H Nelson, Melanie B Thomas,[...]. J Hematol Oncol 2017
57
14

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Gary Middleton, Paul Silcocks, Trevor Cox, Juan Valle, Jonathan Wadsley, David Propper, Fareeda Coxon, Paul Ross, Srinivasan Madhusudan, Tom Roques,[...]. Lancet Oncol 2014
178
14

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma.
Gary Middleton, William Greenhalf, Eithne Costello, Victoria Shaw, Trevor Cox, Paula Ghaneh, Daniel H Palmer, John P Neoptolemos. Br J Cancer 2016
11
18


Telomere-driven diseases and telomere-targeting therapies.
Paula Martínez, Maria A Blasco. J Cell Biol 2017
99
14


Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells.
Sutapa Chakraborty, Utpal Ghosh, N P Bhattacharyya, R K Bhattacharya, Madhumita Roy. Mutat Res 2006
73
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.